Patent US4347236A successfully refreshed from Google Patents.
US4347236A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the preparation of a mixture of an anti-inflammatory steroid and a fluoro-chloro-hydrocarbon to be used as a propellant
Assignee: Orion Oyj
•
Filing: 1981-05-19
•
Granted: 1982-08-31
•
Expires: 2001-05-19
Abstract
Abstract A process by means of which an increase in the particle size of a micro-ground anti-inflammatory steroid in the aerosol propellant is prevented. The increase in the particle size is prevented at the suspending stage when the solubility of the steroid into the propellant is reduced by using a low temperature and by initially mixing only a little quantity of the propellant with the steroid. If desired, the smallest and dissolved steroid particles can be removed by filtering. The particle size does not become larger even afterwards when the suspension is allowed to be stabilized for a sufficiently long time before the temperature is raised or the rest of the propellant is added.
Inventors
- 👤 Paavo T. Tanskanen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 12:58
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/007; A61K9/0073; A61K9/008; A61P; A61P29/00; C; C09; C09K; C09K3/00; C09K3/30
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
142 words
A process for preparing a stable aerosol formulation of beclomethasone dipropionate in a fluoro-chlorohydrocarbon propellant wherein the beclomethasone dipropionate has a particle size smaller than 5 μm, said process comprising suspending beclomethasone dipropionate, ground into a particle size smaller than 5 μm, in a small quantity of a fluoro-chlorohydrocarbon propellant at a temperature of from about -40° to +5° C., stirring the resultant mixture for at least 24 hours at a temperature of from about -40° to +5° C. in the course of which time the mixture is brought to the stabilization stage, and adding to the stabilized mixture during or after said stirring a further quantity of the propellant sufficient to make an aerosol formulation suitable for use in inhalation therapy, whereby increase in the particle size of the beclomethasone dipropionate is substantially prevented throughout said process and during subsequent storage.
Claim 2
Dependent Claim
142 words
A process for preparing a stable aerosol formulation of beclomethasone dipropionate in a fluoro-chlorohydrocarbon propellant wherein the beclomethasone dipropionate has a particle size smaller than 5 μm, said process comprising suspending beclomethasone dipropionate, ground into a particle size smaller than 5 μm, in a small quantity of a fluoro-chlorohydrocarbon propellant at a temperature of from about -40° to +5° C., stirring the resultant mixture for at least 24 hours at a temperature of from about -40° to +5° C. in the course of which time the mixture is brought to the stabilization stage, and adding to the stabilized mixture during or after said stirring a further quantity of the propellant sufficient to make an aerosol formulation suitable for use in inhalation therapy, whereby increase in the particle size of the beclomethasone dipropionate is substantially prevented throughout said process and during subsequent storage.
Claim 3
Dependent Claim
15 words
A process as claimed in claim 1, wherein the fluoro-chloro-hydrocarbon propellant is trichlorofluoromethane or dichlorodifluoromethane.
Claim 4
Dependent Claim
19 words
A process as claimed in claim 1 or 2, wherein the mixture is stirred for 1 to 3 days.
Claim 5
Dependent Claim
28 words
A process as claimed in claim 1 or 2, wherein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about -40° to -10° C.
Claim 6
Dependent Claim
26 words
A process as claimed in claim 3, wherein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about -40° to -10° C.
Claim 7
Dependent Claim
25 words
A process as claimed in claim 1, wherein the beclomethasone dipropionate is suspended in trichlorofluoromethane at a temperature of from about -25° to -15° C.
Claim 8
Dependent Claim
25 words
A process as claimed in claim 1, wherein the beclomethasone dipropionate is suspended in dichlorodifluoromethane at a temperature of from about -35° to -25° C.
Claim 9
Dependent Claim
29 words
A process as clamed in claim 1 or 2, wherein the suspension is filtered during the stirring stage by means of a membrane filter of 0.2 to 0.5 μm.
Claim 10
Dependent Claim
27 words
A process as claimed in claim 3, wherein the suspension is filtered during the stirring stage by means of a membrane filter of 0.2 to 0.5 μm.
Claim 11
Dependent Claim
26 words
A process as claimed in claim 8, wherein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about -10° to +5° C.
Claim 12
Dependent Claim
26 words
A process as claimed in claim 9, wherein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about -10° to +5° C.
Claim 13
Dependent Claim
26 words
A process as claimed in claim 9, wheein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about 0° to +5° C.
Claim 14
Dependent Claim
26 words
A process as claimed in claim 9, wherein the beclomethasone dipropionate is suspended in the propellant at a temperature of from about 0° to +5° C.
Claim 15
Dependent Claim
33 words
A process as claimed in claim 1, 2 or 6, wherein the quantity of propellant used in the suspending stage is 1 to 10 percent by weight of the total quantity of propellant.
Claim 16
Dependent Claim
30 words
A process as claimed in claim 11, wherein the quantity of propellant used in the suspending stage is 1 to 10 percent by weight of the total quantity of propellant.
Claim 17
Dependent Claim
30 words
A process as claimed in claim 4, wherein the quantity of propellant used in the suspending stage is 1 to 10 percent by weight of the total quantity of propellant.
Claim 18
Dependent Claim
30 words
A process as claimed in claim 5, wherein the quantity of propellant used in the suspending stage is 1 to 10 percent by weight of the total quantity of propellant.
References Cited (Backward Citations)
US4225597A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-08-30 | 1986-03-01 | 1986-08-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-08-30 | 1990-03-01 | 1990-08-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-08-30 | 1994-03-01 | 1994-08-31 | $7700.00 | Window Closed / Lapsed |